Attovia Therapeutics, Inc. (ATTO)

SEC filing

Attovia Therapeutics, Inc.

ATTO · CIK 2058707

4 · Aug 7, 2026 · Redmile Biopharma Investments III bought 600K shares at $17.00/share ($10.2M); converted 782.85K shares

Redmile Biopharma Investments III bought 600K shares at $17.00/share ($10.2M); converted 782.85K shares

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.